8 results
10-Q
2022 Q1
HLVX
HilleVax Inc
8 Jun 22
Quarterly report
4:25pm
or innovative products before they will reimburse healthcare providers who use such products. It is difficult to predict at this time what third … Innovation at CMS to test innovative payment and service delivery models to lower Medicare and Medicaid spending.
Since its enactment, there have been
424B4
HLVX
HilleVax Inc
29 Apr 22
Prospectus supplement with pricing info
4:02pm
third-party payors may require pre-approval of coverage for new or innovative products before they will reimburse healthcare providers who use … for such research; and established a Center for Medicare Innovation at CMS to test innovative payment and service delivery models to lower Medicare
S-1/A
HLVX
HilleVax Inc
18 Apr 22
IPO registration (amended)
6:08am
the extent to which new vaccines will be covered. Some third-party payors may require pre-approval of coverage for new or innovative products before … effectiveness research, along with funding for such research; and established a Center for Medicare Innovation at CMS to test innovative payment and service
S-1
b3i8guxq9to8s
6 Apr 22
IPO registration
4:21pm
DRS/A
01eli
23 Nov 21
Draft registration statement (amended)
12:00am
DRS
vni 373mcxuf
19 Oct 21
Draft registration statement
12:00am
- Prev
- 1
- Next